Abstract
Therapeutic hypothermia reduces the incidence of severe motor disability, such as cerebral palsy, following neonatal hypoxic-ischemic encephalopathy. However, cooled children without cerebral palsy at school-age demonstrate motor deficits and altered white matter connectivity. In this study, we used diffusion-weighted imaging to investigate the relationship between white matter connectivity and motor performance, measured using the Movement Assessment Battery for Children-2, in school-age children treated with therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy at birth, who did not develop cerebral palsy (cases), and matched controls. Analysis of tract-level microstructure (33 cases, 36 controls) revealed correlations between total motor scores and fractional anisotropy, in cases but not controls, in the anterior thalamic radiation bilaterally, the inferior fronto-occipital fasciculus bilaterally and both the hippocampal and cingulate gyrus parts of the left cingulum. Analysis of structural brain networks (22 cases, 32 controls), in which edges were determined by probabilistic tractography and weighted by fractional anisotropy, revealed correlations between total motor scores and several whole-brain network metrics in cases but not controls. We then investigated edge-level association with motor function using the network-based statistic. This revealed subnetworks which exhibited group differences in the association between motor outcome and edge weights, for total motor scores as well as for balance and manual dexterity domain scores. All three of these subnetworks comprised numerous frontal lobe regions known to be associated with motor function, including the superior frontal gyrus and middle frontal gyrus. These findings demonstrate an association between impaired motor function and brain organisation in case children.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Baily Thomas Charitable Fund (TRUST/VC/AC/SG4681-7596), David Telling Charitable Trust, as well as Sparks (05/BTL/01 and 14/BTL/01) and the Moulton Foundation. AS is supported by the Wellcome Trust (WT220070/Z/20/Z). JB is supported by the UK Medical Research Council (MR/N026969/1). MG is supported by the EPSRC (EP/N014391/1) and by a Wellcome Trust Institutional Strategic Support Award (WT105618MA).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the North Bristol Research Ethics Committee and the Health Research Authority (REC ID: 15/SW/0148).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data availability statement The raw data that support these findings are available upon reasonable request to the corresponding author.
Funding statement This work was supported by the Baily Thomas Charitable Fund (TRUST/VC/AC/SG4681-7596), David Telling Charitable Trust, as well as Sparks (05/BTL/01 and 14/BTL/01) and the Moulton Foundation. AS is supported by the Wellcome Trust (WT220070/Z/20/Z). JB is supported by the UK Medical Research Council (MR/N026969/1). MG is supported by the EPSRC (EP/N014391/1) and by a Wellcome Trust Institutional Strategic Support Award (WT105618MA).
Conflict of interest disclosure The authors have no conflicts of interest to declare.
Ethics approval statement Ethical approval was obtained from the North Bristol Research Ethics Committee and the Health Research Authority (REC ID: 15/SW/0148).
Patient consent statement Informed and written consent was obtained from the parents of participants, in accordance with the Declaration of Helsinki.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.